Detalles de la búsqueda
1.
Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial.
Phytomedicine
; 130: 155457, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38810556
2.
Add-on Rehmannia-6-Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled Trial.
Clin J Am Soc Nephrol
; 18(9): 1163-1174, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37307005
3.
Screening for diabetic retinopathy with different levels of financial incentive in a randomized controlled trial.
J Diabetes Investig
; 12(9): 1632-1641, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33484625
4.
Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial.
BMJ Open
; 11(1): e042686, 2021 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33436470
5.
Distinct profiles of cognitive impairment associated with different silent cerebrovascular lesions in hypertensive elderly Chinese.
J Neurol Sci
; 403: 139-145, 2019 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31284183
6.
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial.
BMJ Open
; 6(8): e010741, 2016 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27496229
Resultados
1 -
6
de 6
1
Próxima >
>>